Literature DB >> 19180661

Rotational vs. standard coronary angiography: an image content analysis.

Joel A Garcia1, Pierfrancesco Agostoni, Nathan E Green, James T Maddux, S-Y James Chen, John C Messenger, Ivan P Casserly, Adam Hansgen, Onno Wink, Babak Movassaghi, Bertron M Groves, Paul Van Den Heuvel, Stefan Verheye, Glenn Van Langenhove, Paul Vermeersch, Frank Van den Branden, Yerem Yeghiazarians, Andrew D Michaels, John D Carroll.   

Abstract

OBJECTIVE: To evaluate the clinical utility of images acquired from rotational coronary angiographic (RA) acquisitions compared to standard "fixed" coronary angiography (SA).
BACKGROUND: RA is a novel angiographic modality that has been enabled by new gantry systems that allow calibrated automatic angiographic rotations and has been shown to reduce radiation and contrast exposure compared to SA. RA provides a dynamic multiple-angle perspective of the coronaries during a single contrast injection.
METHODS: The screening adequacy, lesion assessment, and a quantitative coronary analysis (QCA) of both SA and RA were compared by independent blinded review in 100 patients with coronary artery disease (CAD).
RESULTS: SA and RA recognize a similar total number of lesions (P = 0.61). The qualitative assessment of lesion characteristics and severity between modalities was comparable and lead to similar clinical decisions. Visualization of several vessel segments (diagonal, distal RCA, postero-lateral branches and posterior-descending) was superior with RA when compared to SA (P < 0.05). A QCA comparison (MLD, MLA, LL, % DS) revealed no difference between SA and RA. The volume of contrast (23.5 +/- 3.1 mL vs. 39.4 +/- 4.1; P = 0.0001), total radiation exposure (27.1 +/- 4 vs. 32.1 +/- 3.8 Gycm(2); P = 0.002) and image acquisition time (54.3 +/- 36.8 vs. 77.67 +/- 49.64 sec; P = 0.003) all favored RA.
CONCLUSION: Coronary lesion assessment, coronary screening adequacy, and QCA evaluations are comparable in SA and RA acquisition modalities in the diagnosis of CAD however RA decreases contrast volume, image acquisition time, and radiation exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19180661     DOI: 10.1002/ccd.21918

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Measurement of peripheral arterial vasculature in domestic Yorkshire swine by using quantitative vascular angiography.

Authors:  Vanessa C Lopes-Berkas; Michael A Jorgenson
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

2.  Correlation between dual-axis rotational coronary angiography and intravascular ultrasound in a coronary lesion assessment.

Authors:  Zhi-Geng Jin; Zhuo-Qi Zhang; Li-Min Jing; Yu-Jie Wei; Jiao Zhang; Jian-Ping Luo; Sheng-Li Yang; Dong-Xing Ma; Ying Liu; Wei Han; Yong Yang; Hui-Liang Liu
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-11       Impact factor: 2.357

3.  Diagnostic Utility of Three-Dimensional Rotational Angiography in Congenital Cardiac Catheterization.

Authors:  Osamah Aldoss; Brian M Fonseca; Uyen T Truong; John Bracken; Jeffrey R Darst; Ruixin Guo; Tamekia L Jones; Thomas E Fagan
Journal:  Pediatr Cardiol       Date:  2016-06-09       Impact factor: 1.655

4.  Benefits of dual-axis rotational coronary angiography in routine clinical practice.

Authors:  Ahmad Farshid; Jaya Chandrasekhar; Donald McLean
Journal:  Heart Vessels       Date:  2013-04-25       Impact factor: 2.037

5.  Dual-axis rotational coronary angiography: a new technique for detecting graft coronary vasculopathy in pediatric heart transplant recipients.

Authors:  Todd M Gudausky; Andrew N Pelech; Gail Stendahl; Kathryn Tillman; Judy Mattice; Stuart Berger; Steven Zangwill
Journal:  Pediatr Cardiol       Date:  2012-09-06       Impact factor: 1.655

6.  Comparison of diagnostic accuracy of dual-axis rotational versus standard coronary angiography.

Authors:  Zhi-Geng Jin; Rui Bai; Yi Li; Yong Yang; Wei Han; Qing Zhao; Lu Zhang; Hui-Liang Liu
Journal:  Int J Cardiovasc Imaging       Date:  2019-10-18       Impact factor: 2.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.